Efficacy of Ciclesonide During the Cold Season in Patients Older Than 12 Years With Persistent Asthma

The aim of the study is to evaluate the efficacy of ciclesonide in patients with persistent asthma over 3 months, especially in the cold season. Ciclesonide will be inhaled by a metered-dose inhaler. The study will provide further data on safety and tolerability of ciclesonide.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Asthma Bronchial Diseases Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Lung Diseases Lung Diseases, Obstructive Respiratory Hypersensitivity Respiratory Tract Diseases

Age range

12 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

"Nycomed Deutschland GmbH", Adendorf, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Main inclusion criteria:

History of persistent bronchial asthma

Main exclusion criteria:

Hypersensitive to compounds of Alvesco
Other criteria as defined in the Summary of Product Characteristics (Fachinformation Chapter 4.3)

Treatment and study plan

Ciclesonide

Drug

This is an observational study. Therefore, the physician decides about dosage according to individual needs.

Primary outcomes

FEV1, symptom score assessment

Time frame: within 3 months

Secondary outcomes

Handling of the metered-dose inhaler, safety and tolerability

Time frame: within 3 months

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

Ciclesonide for the Therapy of Asthma During the Cold Season.

Acronym: ARTIST

Important dates

Study start: 2008
Primary completion: 2008
Study completion: 2008
First posted: Feb 6, 2008
Registry last updated: Dec 5, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed